Min‐Wei Chen
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
Papers in
-
- Wnt/β-catenin signaling in development and cancer 3
- Angiogenesis and VEGF in Cancer 3
- Epigenetics and DNA Methylation 3
- Surgery 6
- Co-authors
- Ralph Buttyan (15 shared papers)Anthony J. Raffo (1 shared paper)Harris Perlman (1 shared paper)Mark L. Day (1 shared paper)Martin Burchardt (11 shared papers)Alexandre de la Taille (9 shared papers)Ralph Buttyan (6 shared papers)Michael Hsiao (4 shared papers)
- Journals
- The Journal of Urology (5 papers)The Prostate (4 papers)IUBMB Life (2 papers)European Journal of Pharmacology (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Min‐Wei Chen
54 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 364
- Pulmonary and Respiratory Medicine 561
- Urology 106
- Molecular Biology 1.2k
- Oncology 387
Countries citing papers authored by Min‐Wei Chen
This map shows the geographic impact of Min‐Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Wei Chen more than expected).
Fields of papers citing papers by Min‐Wei Chen
This network shows the impact of papers produced by Min‐Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Wei Chen. The network helps show where Min‐Wei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Min‐Wei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. | 1995 | 480 |
| 2 | 2014 | 179 | |
| 3 | 2010 | 162 | |
| 4 | 1999 | 152 | |
| 5 | 2014 | 134 | |
| 6 | Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. | 2003 | 132 |
| 7 | Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. | 1997 | 102 |
| 8 | 2002 | 83 | |
| 9 | 2006 | 81 | |
| 10 | 2011 | 77 | |
| 11 | 1999 | 72 | |
| 12 | 2011 | 52 | |
| 13 | 2002 | 52 | |
| 14 | 2013 | 46 | |
| 15 | 2019 | 46 | |
| 16 | 1999 | 45 | |
| 17 | 1994 | 44 | |
| 18 | 2018 | 44 | |
| 19 | 2016 | 43 | |
| 20 | 1995 | 41 |
About Min‐Wei Chen
Min‐Wei Chen is a scholar working on Molecular Biology, Surgery, Pathology and Forensic Medicine, Oncology and Pharmacology, having authored 54 papers that have together received 2.5k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (4 papers), Prostate Cancer Treatment and Research (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Epigenetics and DNA Methylation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Cancer Research (364 citations), Pulmonary and Respiratory Medicine (561 citations), Urology (106 citations), Molecular Biology (1.2k citations) and Oncology (387 citations). Min‐Wei Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ralph Buttyan, Anthony J. Raffo, Harris Perlman, Mark L. Day, Martin Burchardt, Alexandre de la Taille, Ralph Buttyan, Michael Hsiao, Francis Vacherot and Tatjana Burchardt. Their work appears in journals such as The Journal of Urology, The Prostate, IUBMB Life, European Journal of Pharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.